
pmid: 26654259
The metabolic syndrome is a multiplex risk factor for atherosclerotic cardiovascular disease and type 2 diabetes. It is composed of atherogenic dyslipidemia, elevated blood pressure, insulin resistance and elevated glucose, a pro-thrombotic state, and a pro-inflammatory state. Excess energy intake and concomitant obesity are the major drivers of the syndrome. Lifestyle intervention can reverse metabolic risk factors, but at times, drug therapies or bariatric surgery may be required to control more overt risk factors.
Metabolic Syndrome, Bariatric Surgery, Cardiovascular Agents, Atherosclerosis, Treatment Outcome, Risk Factors, Hyperglycemia, Hypertension, Humans, Hypoglycemic Agents, Obesity, Risk Reduction Behavior, Dyslipidemias, Hypolipidemic Agents
Metabolic Syndrome, Bariatric Surgery, Cardiovascular Agents, Atherosclerosis, Treatment Outcome, Risk Factors, Hyperglycemia, Hypertension, Humans, Hypoglycemic Agents, Obesity, Risk Reduction Behavior, Dyslipidemias, Hypolipidemic Agents
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 685 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 0.1% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 1% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 0.1% |
